| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |